Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Shareholder Vote On 6 June For Virtus-Backed Offer From CapVest

Virtus Enters Into Firm Deal With CapVest

Virtus Health Backs CapVest's Revised Bid

Quiddity Advisors

Event-Driven

<ul>
<li>
CapVest has bumped its Scheme Offer for <a href="https://www.smartkarma.com/entities/virtus-health-ltd" target="_blank" data-smartkarma-citation="entities:14776:1" rel="noopener">Virtus Health (VRT AU)</a> to A$8.15/share. More importantly, it has increased the Takeover Offer price to A$8.10/share.</li>
<li>Separately, the Takeovers Panel has made interim orders prohibiting BGH from acquiring on market any Virtus shares above its Bid Price.</li>
<li>Virtus's Board has unanimously determined that CapVest's revised Offer is superior to BGH's Bid. </li>
</ul>



CapVest has bumped its Scheme Offer for Virtus Health (VRT AU) to A$8.15/share. More importantly, it has increased the Takeover Offer price to A$8.10/share.
Separately, the Takeovers Panel has made interim orders prohibiting BGH from acquiring on market any Virtus shares above its Bid Price.
Virtus's Board has unanimously determined that CapVest's revised Offer is superior to BGH's Bid. 


The Panel Joins CapVest In Virtus' Corner